Estimating the Effectiveness of Acellular Pertussis Vaccines
Open Access
- 7 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (10) , 1432-1433
Abstract
To the Editor—In the 15 June 2012 issue of Clinical Infectious Diseases, Witt et al reported that vaccine effectiveness (VE) of acellular pertussis vaccines was 41% for children aged 2–7 years, 24% for 8- to 12-year-olds, and 79% for 13- to 18-year-olds [1]. The authors conclude that their data “confirms markedly lower than expected protection afforded by the pre-school series of acellular pertussis vaccinations in the 8–12 year age group” and poor durability of protection from the vaccine. While we agree that protection wanes over time, there are important limitations to the Witt et al analysis.Keywords
This publication has 3 references indexed in Scilit:
- Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American OutbreakClinical Infectious Diseases, 2012
- Effectiveness of the Pertussis Vaccination Program as Determined by Use of the Screening Method: United States, 1992–1994The Journal of Infectious Diseases, 1997
- ASSESSING VACCINE EFFICACY IN THE FIELDEpidemiologic Reviews, 1988